INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Replimune Group (REPL) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Core Points - A shareholder class action lawsuit has been filed against Replimune Group, Inc. alleging that the company made materially false and misleading statements regarding the IGNYTE trial's prospects [1] - The lawsuit claims that the defendants overstated the trial's prospects despite known material issues, leading the FDA to deem the trial inadequate and not well-controlled [1] - As a result of these actions, the statements made by the defendants about Replimune's business, operations, and prospects were considered materially false and misleading [1] Legal Information - Shareholders who purchased Replimune shares between November 22, 2024, and July 21, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed as lead plaintiff in the case is September 22, 2025 [3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]